Hsinchu County, Taiwan

Hsiang-Kai Lin


 

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsiang-Kai Lin: Innovator in Hepatitis B Therapeutic Vaccines

Introduction

Hsiang-Kai Lin is a notable inventor based in Hsinchu County, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of therapeutic vaccines for hepatitis B. His innovative work has the potential to impact public health positively.

Latest Patents

Hsiang-Kai Lin holds a patent for a hepatitis B therapeutic vaccine. The patent describes a fusion protein designed for use as a therapeutic vaccine against hepatitis B. This fusion protein includes an antigen-presenting cell (APC)-binding domain or a CD91 receptor-binding domain, a protein transduction domain, and an antigen comprising a hepatitis B virus X protein deletion mutant. The protein transduction domain is a fusion polypeptide that consists of a T cell sensitizing signal-transducing peptide, a linker, and a translocation peptide. The APC-binding domain or the CD91 receptor-binding domain is positioned at the N-terminus of the fusion protein, while the antigen is located at the C-terminus of the protein transduction domain. Hsiang-Kai Lin's patent represents a significant advancement in the fight against hepatitis B, with 1 patent to his name.

Career Highlights

Hsiang-Kai Lin is associated with Thevax Genetics Vaccine Co., Ltd., where he continues to work on innovative solutions in vaccine development. His expertise in the field has positioned him as a key figure in the advancement of therapeutic vaccines.

Collaborations

Hsiang-Kai Lin collaborates with notable colleagues, including Chia-Mao Wu and Jiun-Ming Wu. Their combined efforts contribute to the ongoing research and development in the field of vaccines.

Conclusion

Hsiang-Kai Lin's work in developing a hepatitis B therapeutic vaccine showcases his dedication to medical innovation. His contributions are vital in the ongoing battle against infectious diseases, and his patent reflects the potential for significant advancements in vaccine technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…